Gene · 54915
Papers3,036
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 3,036
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| METTL3 Uncouples Chromatin Accessibility from Transcription during Retinal Development. | bioRxiv | 2025 | 41256642 | PubTator, text mining | PubMed |
| Sodium-myoinositol cotransporter-1 downstream of m6A methyltransferase WTAP exerts a potential carcinogenicity in diffuse large B-cell lymphoma progression. | J Transl Med | 2025 | 41254747 | PubTator, text mining | PubMed |
| Impact of TRMT6 on prognosis and immune microenvironment in ovarian cancer. | Front Oncol | 2025 | 41244907 | PubTator, text mining | PubMed |
| YTHDF1 regulates YTHDF2 stability via m6A-dependent mechanisms in hepatocellular carcinoma: insights from in vitro, in vivo, and multi-cohort clinical studies. | J Gastrointest Oncol | 2025 | 41220748 | PubTator, text mining | PubMed |
| The methyltransferase-like proteins as core regulators of nucleic acid modifications and post-translation modification of proteins in disease pathogenesis and therapeutic implications. | Biomark Res | 2025 | 41194259 | PubTator, text mining | PubMed |
| Energy status orchestrates YTHDF1 phase separation and tumorigenesis. | Cell Rep | 2025 | 41171760 | PubTator, text mining | PubMed |
| The m6A reader YTHDF1 facilitates nasopharyngeal carcinoma proliferation and migration via c-MYC. | J Biol Chem | 2025 | 41167308 | PubTator, text mining | PubMed |
| Influence of m6A regulatory factor related to immune microenvironment on the prognosis of prostate cancer. | Biomed Eng Online | 2025 | 41163172 | PubTator, text mining | PubMed |
| The role of YTHDF1 in the diagnosis and prognosis of lung adenocarcinoma and its inhibitor LY-411575 in the targeted intervention of lung adenocarcinoma growth. | Transl Cancer Res | 2025 | 41158226 | PubTator, text mining | PubMed |
| N6-methyladenosine reader YTHDF1 mediates neuronal apoptosis induced by aluminum via m6A/Bcl-2 manner. | Ecotoxicol Environ Saf | 2025 | 41151285 | PubTator, text mining | PubMed |
| METTL3 uncouples chromatin accessibility from transcription during retinal development. | Stem Cell Reports | 2025 | 41135527 | PubTator, text mining | PubMed |
| Identification of a novel m6A RNA methylation regulator-based signature for prognosis and immune landscape prediction in hepatocellular carcinoma. | Sci Rep | 2025 | 41120498 | PubTator, text mining | PubMed |
| METTL3: A dual regulator of oral tissue regeneration and malignancy with therapeutic implications for stem cell therapy and chemoresistance. | Sci Prog | 2025 | 41118452 | PubTator, text mining | PubMed |
| Long non-coding RNA FEZF1-AS1 suppresses ferroptosis in multiple myeloma cells through KIAA1429-mediated m6A modification. | Hum Cell | 2025 | 41085851 | PubTator, text mining | PubMed |
| Arsenic regulates ALKBH1 abundance and substrate specificity to promote translation and tumorigenicity. | Cell Rep | 2025 | 41046516 | PubTator, text mining | PubMed |
| VISTA expressed on tumor cells is regulated by m6A and influences immune microenvironment through STAT3/CCL22 in NSCLC. | J Transl Med | 2025 | 41039458 | PubTator, text mining | PubMed |
| Local translation under epitranscriptomic control. | Trends Neurosci | 2025 | 41033857 | PubTator, text mining | PubMed |
| METTL14 knockdown augmented the polarization of M2-like macrophages to promote acute myeloid leukemia progression. | Hum Cell | 2025 | 41026373 | PubTator, text mining | PubMed |
| ALKBH1 Gene rs6494 T>A Polymorphism Decreases Wilms Tumour Risk in Chinese Children. | J Cell Mol Med | 2025 | 41017026 | PubTator, text mining | PubMed |
| Identification of prognostic biomarkers for hepatocellular carcinoma based on the m6A RNA modification. | Int J Immunopathol Pharmacol | 2025 | 41013996 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/54915/papers?page=7